Changes and Challenges Ahead for Controlled Substance Manufacturers

pharmafile | June 7, 2012 | Feature | Manufacturing and Production |   

Recently, several major suppliers of clinical supply services, including Catalent Pharma Solutions, have
undertaken major expansions for controlled drugs on a global scale. In many cases, these expansions have
increased the existing capacities by more than two to threefold. In this article Corey McGeehan, Regulatory Compliance Manager – US Clinical Supply Services discusses the trends and mindset fueling this growth. Click the link below to download a copy of the article:

http://solutions.catalent.com/controlleddrugdl?elq=16e37552f719413fbef6b753032df391&elqCampaignId=155